Publication date: Available online 22 November 2018
Source: International Journal of Pediatric Otorhinolaryngology
Author(s): Yanhui Liu, Lixin Ye, Pengyuan Zhu, Jingfan Wu, Shujuan Tan, Jingguo Chen, Chunqiu Wu, Yukang Zhong, Yu Wang, Xiaoxia Li, Hailiang Liu
Abstract
In order to investigate essential molecular causes for hearing loss and mutation frequency of deafness-related genes, 1315 newborns who did not pass the Newborn Hearing Screening (NHS) (audio-no-pass) and 1000 random-selected infants were subjected to detection for 101 hotspot mutations in 18 common deafness-related genes. Totally, 23 alleles of 7 deafness genes were detected out. Significant difference (χ2=25.320, p=0.000) existed in causative mutation frequency between audio-no-pass group (81/1315, 6.160%) and random-selected cohort (18/1000, 1.80%). Of the genes detected out, GJB2 gene mutation was with significant difference (χ2=75.132, p=0.000) between audio-no-pass group (417/1315, 31.711%) and random-selected cohort (159/1000, 15.900%); c.109G>A was the most common allele, as well as the only one with significantly different allele frequency (χ2=79.327, p=0.000) between audio-no-pass group (392/1315, 16.84%) and random-selected cohort (140/1000, 7.55%), which suggested c.109G>A mutation was critical for newborns' hearing loss. This study performed detection for such a large scale of deafness-associated genes and for the first time compared mutations between audio-no-pass and random-recruited neonates, which not only provided more reliable DNA diagnosis result for medical practioners and enhanced clinical care for the newborns, but gave more accurate estimation for mutation frequency.
https://ift.tt/2DVkQx3
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου